VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | Improving the efficacy of CAR-T therapy in multiple myeloma through SUMOylation inhibition

Li Du, PhD, City of Hope Comprehensive Cancer Center, Duarte, CA, comments on the impact of SUMOylation inhibition on the efficacy of CAR-T therapy in multiple myeloma. It has been shown that inhibiting SUMOylation prevents T-cell exhaustion and prolongs CAR-T persistence. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter